Robert Oldham Young*

Department of Research, Innerlight, Biological Research and Health Education Foundation, USA

*Corresponding Author: Robert Oldham Young, Department of Research, Innerlight, Biological Research and Health Education Foundation, USA.

Received: December 09, 2024; Published: March 25, 2025

Abstract

This article critically evaluates the claims made in "Plaquex – The Miracle Molecule and Zeolite Dangers", featuring insights from Professor Anita Baxas, MD, and Dr. Ana Maria Mihalcea, MD, PhD. The discussion covers Plaquex, a patented phosphatidylcholine (PC) therapy for reversing atherosclerosis, regenerating cell membranes, and enhancing cognitive function, alongside allegations of heavy metal contamination and self-assembling nanotechnology in certain zeolite products. This review examines the scientific validity of these assertions, highlights critical evidence gaps, and suggests recommendations for rigorous evaluation. While Plaquex demonstrates potential in cardiovascular and cognitive health, exaggerated claims about cellular regeneration and nanotechnology resilience remain unproven. Allegations of zeolite contamination necessitate independent validation and improved transparency from manufacturers.

Keywords: Plaquex; Phosphatidylcholine; Zeolites; Heavy Metals; Nanotechnology; Detoxification; Atherosclerosis; Chelation

References

1. Beilstein F., et al. “Phosphatidylcholine and Its Role in Cardiovascular Health”. Journal of Lipid Research 3 (2020): 123-135.
2. Davidson MH. “Clinical Utility of Phosphatidylcholine in Lipid Metabolism Disorders”. Cardiology Clinics 2 (2021): 171-180.
3. Cansev M., et al. “Phosphatidylcholine and Cognitive Function”. Frontiers in Neuroscience 10 (2016): 183.
4. Libby P., et al. “Inflammation and Atherosclerosis”. Cell 6 (2010): 885-895.
5. Nanotechnology Study Group. “Evaluating Biological Responses to Nanotechnology”. Nature Nanotechnology 16 (2021): 57-68.
6. Zeisel SH. “Choline and Phosphatidylcholine in Health and Disease”. Annual Review of Nutrition 24 (2019): 257-281.
7. Verstraeten S., et al. “Emerging Roles of Phosphatidylcholine in Cell Regeneration”. Molecular and Cellular Biochemistry 1 (2022): 191-202.
8. “Toxicological Profile for Uranium”. Agency for Toxic Substances and Disease Registry (2020.
9. Brown TL., et al. “Zeolites: Chemistry and Applications in Detoxification”. Chemistry of Materials 8 (2021): 2615-2630.
10. McNamara K., et al. “Ensuring Quality in Pharmaceutical-Grade Zeolites”. Journal of Pharmaceutical Sciences 4 (2020): 1412-1423.
11. Campra J., et al. “Nanotechnology and Crystalline Patterns in Zeolite Microscopy”. Microscopy Research 3 (2023): 67-74.
12. Yanowitz S. “Advanced Spectroscopy of Nanomaterials in Medical Products”. Journal of Applied Nanotechnology 15 (2022): 123-139.
13. Kosnett MJ. “Chelation Therapy for Heavy Metal Poisoning”. Toxicology Review 6 (2020): 567-589.
14. “Standard Methods for Metal Analysis in Pharmaceuticals”. ISO 9001 Certification (2022.
15. Gupta S., et al. “Zeolites and Human Health: Current Perspectives”. Environmental Toxicology and Pharmacology 84 (2021): 103602.
16. “Scientific Opinion on the Safety of Zeolites”. European Food Safety Authority Journal 18.3 (2020): 1467-1483.
17. Gröne HJ., et al. “Phosphatidylcholine in Cardiovascular Clinical Trials”. Atherosclerosis Supplements 35 (2018): 189-198.

Citation

Citation: Robert Oldham Young. “A Critical Review of “Plaquex – The Miracle Molecule and Zeolite Dangers”".Acta Scientific Medical Sciences 9.4 (2025): 111-113.

Copyright

Copyright: © 2025 Robert Oldham Young. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.